Skip to main content
. Author manuscript; available in PMC: 2024 Mar 18.
Published in final edited form as: Clin Infect Dis. 2023 Sep 18;77(6):901–909. doi: 10.1093/cid/ciad289

Table 4.

Age at First Viral Infection and Proportion of Cohort Who Experienced at Least 1 Respiratory Viral Infection Detected by PCR of a Nasal Swab in the Highly Adherent PREVAIL Cohort (n = 101), by Respiratory Virus

Proportion of Cohort With at Least 1 Viral Infection Detected by Nasal Swab
Pathogen Age at First Viral Infection,a mo By 12 Months By 24 Months
Adenovirus 8 (6–11)b 48% 59%
Bocavirus 10 (6–15)c 50% 77%
Endemic coronavirus 11 (6–17) 55% 79%
 229E 18 (11–19) 3% 9%
 HKU1 13 (7–18) 20% 45%
 NL63 11 (5–15.5) 23% 44%
 OC43 11 (6–13) 31% 50%
Influenza virus 17 (10–20) 11% 27%
 Influenza A 17 (10–20) 9% 25%
 Influenza B 11.5 (6–20) 2% 4%
 Human metapneumovirus 11 (8–18) 24% 47%
Parainfluenza virus 12 (7–17) 50% 82%
 PIV1 18.5 (15–21.5) 3% 20%
 PIV2 9 (7–13) 9% 17%
 PIV3 10 (6–14) 38% 57%
 PIV4 15 (9–19) 10% 31%
Rhino/enterovirus 2 (1–3)d 97% 100%
Respiratory syncytial virus 12 (7–18) 40% 66%
 RSV A 15.5 (9–19) 16% 42%
 RSV B 9 (6–17) 25% 41%

Abbreviations: PCR, polymerase chain reaction; PREVAIL, Pediatric Respiratory and Enteric Virus Acquisition and Immunogenesis Longitudinal; RSV, respiratory syncytial virus.

a

Presented as median (interquartile range).

b

Significantly differs from median age at first viral infection of influenza virus (P = .005), parainfluenza virus (P = .013), and RSV (P = .018).

c

Significantly differs from median age at first viral infection of influenza virus (P = .005).

d

Significantly differs from median age at first viral infection of all other respiratory virus using Kruskal–Wallis, P ≤ .0001.